COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
WHO Executive Board Rejects Israel’s Proposal To Remove Standalone Agenda Item On Palestinian Health Conditions 28/01/2021 Madeleine Hoecklin For the second time in as many years, WHO member states have voted down a proposal by Israel to remove a standalone item from the agenda of the 74th World Health Assembly – devoted exclusively to a report on health conditions in the Occupied Palestinian territories – and consider it as part of WHO’s overall […] Continue reading -> EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
EU Protests AstraZeneca Vaccine Delays – Could Block UK-Bound Exports 28/01/2021 Madeleine Hoecklin AstraZeneca has joined Pfizer in announcing delays in deliveries of COVID-19 vaccines to countries in Europe, leading furious EU officials to plan for a system of tighter monitoring of vaccine exports. The British-Swedish pharma company that developed its COVID-19 vaccine with researchers at Oxford University, informed the European Commission on Friday that there would be […] Continue reading -> Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies 27/01/2021 Paul Adepoju & Svĕt Lustig Vijay While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS […] Continue reading -> Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
Moderna’s COVID-19 Vaccine ‘Safe’ For Most People WHO Experts Say – But No Recommendation For Pregnant Women Or Children 26/01/2021 J Hacker The Moderna COVID-19 vaccine is safe for most people including those with a wide range of underlying medical conditions, according to the World Health Organization’s Strategic Advisory Group of Experts (SAGE) on immunizations. However, the vaccine is not recommended for pregnant women or children as it has not been tested on these groups, according to […] Continue reading -> COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
COVAX Planning Per-Dose Vaccine Levy To Fund Compensation Scheme 26/01/2021 Kerry Cullinan The global COVID-19 vaccine access platform, COVAX, plans to impose a US 10-cent levy on each vaccine dose to fund a compensation scheme for people who suffer from severe adverse reactions to any of the vaccines it supplies. The “no-fault” compensation fund is crucial for countries who join COVAX, as one of the conditions of […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts
Cheaper To Fund Global Vaccines Than Suffer Economic Pandemic Fallout, Finds Study 25/01/2021 Kerry Cullinan Wealthy countries that pursue ‘vaccine nationalism’ when their trading partners don’t have access to the COVID-19 vaccine will pay a far higher economic price than if they invest in ensuring all countries have access to vaccines, according to a comprehensive economic modelling study released today by the World Health Organization (WHO). The study, commissioned by […] Continue reading -> Posts navigation Older postsNewer posts